Example: Heart Attack

Clinical Trials on Pulmonary Alveolar Proteinosis

Total 24 results

NCT02461615

Recruiting

A National Registry For Pulmonary Alveolar Proteinosis

Conditions: Pulmonary Alveolar Proteinosis
NCT03007134

Completed

Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial

Conditions: Pulmonary Alveolar Proteinosis
NCT02835742

Completed

Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan

Conditions: Pulmonary Alveolar Proteinosis, Autoimmune
NCT02243228

Unknown status

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT04544293

Not yet recruiting

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996

Recruiting

The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT03482752

Completed

Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT03231033

Completed

Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT03316651

Unknown status

Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis

Conditions: Pulmonary Alveolar Proteinosis; Treatment
NCT03006146

Recruiting

Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT00901511

Unknown status

Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)

Conditions: Pulmonary Alveolar Proteinosis
NCT01511068

Completed

Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)

Conditions: Hereditary Pulmonary Alveolar Proteinosis
NCT02702180

Completed

Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Conditions: Autoimmune Pulmonary Alveolar Proteinosis
NCT04516577

Recruiting

To Assess the Severity of Pulmonary Alveolar Proteinosis Through Different Methods （DSS, SPSP and SPSP II）

Conditions: Pulmonary Alveolar Proteinosis
NCT01983657

Unknown status

Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.

Conditions: Pulmonary Alveolar Proteinosis
NCT03887169

Completed

Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.

Conditions: Pulmonary Alveolar Proteinosis; Mutation Ala393Thr of the MARS Gene; mutationSer567Leu of the MARS Gene
NCT00030056

Terminated

GM-CSF in Patients With Pulmonary Alveolar Proteinosis

Conditions: Pulmonary Alveolar Proteinosis
NCT00552461

Unknown status

Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

Conditions: Pulmonary Alveolar Proteinosis; Primary Disease
NCT02081092

Completed

Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT

Conditions: Pulmonary Alveolar Proteinosis
NCT02840708

Completed

SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study

Conditions: Pulmonary Alveolar Proteinosis, Autoimmune
NCT01842386

Active, not recruiting

Rituximab for Anti-cytokine Autoantibody-Associated Diseases

Conditions: Pulmonary Alveolar Proteinosis (PAP); Severe Mucocutaneous Candidoasis
NCT02468908

Completed

Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

Conditions: Pulmonary Alveolar Proteinosis; Bronchiectasis; Cystic Fibrosis; Acute Respiratory Distress Syndrome
NCT04326036

Recruiting

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Conditions: Pulmonary Alveolar Proteinosis; COPD; Idiopathic Pulmonary Fibrosis; Viral Pneumonia; Coronavirus Infection; Interstitial Lung Disease
NCT02852928

Recruiting

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Conditions: Lung Diseases, Interstitial; Pulmonary Alveolar Proteinosis; Pulmonary Eosinophilia; Pulmonary Fibrosis; Respiratory Distress Syndrome, Newborn; Child